$RMGL Balance Sheet | Understand Stock

$RMGL

Financial Statements

In USD, except per-share amounts

	Q1 FY2027 As of Aug 31, 2026	Q4 FY2026 As of May 31, 2026	Q3 FY2026 As of Feb 28, 2026	Q2 FY2026 As of Nov 30, 2025	Q1 FY2026 As of Aug 31, 2025	Q4 FY2025 As of May 31, 2025	Q3 FY2025 As of Feb 28, 2025
ASSETS
Current assets
Cash and cash equivalents
Prepayment
Total current assets
Non-current asset
Plant and equipment, net
Total non-current asset
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liability
Accrued liability
Total current liabilities
Total liabilities
Stockholders’ equity
Common stock – Par value $ 0.0001; Authorized: 75,000,000 shares; Issued and outstanding: 23,200,000 and 23,200,000 shares of August 31, 2026 and May 31, 2026, respectively
Additional paid in capital
Accumulated deficit
Total stockholders’ equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Comments